Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | |
| Operating Expenses | 633 |
| Operating Income | -633 |
| Other Income | -48 |
| Pre-tax Income | -681 |
| Net Income Continuous | -681 |
| Net Income | $-681 |
| EPS Basic Total Ops | -0.28 |
| EPS Basic Continuous Ops | -0.28 |
| EPS Diluted Total Ops | -0.28 |
| EPS Diluted Continuous Ops | -0.28 |
| EBITDA(a) | $-633 |